Farmaceutica Remedia (LTS:0M8I) Retained Earnings: lei26.4 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0M8I Farmaceutica Remedia SA LTS:0M8I
59 GF Score
Price lei0.25
GF Value lei0.23
! 8 Warning Signs
View Full Analysis

What is Farmaceutica Remedia Retained Earnings?

Farmaceutica Remedia LTS:0M8I 59 Retained Earnings is lei26.4 Mil as of Mar. 2026. GuruFocus rates LTS:0M8I with a GF Score™ of 59/100 and a GF Value™ of lei0.23. The stock has 8 warning signs investors should review.

Retained earnings is the accumulated portion of net income that is not distributed to shareholders. Farmaceutica Remedia's retained earnings for the quarter that ended in Mar. 2026 was lei26.4 Mil.

Farmaceutica Remedia's quarterly retained earnings increased from Sep. 2025 (lei23.2 Mil) to Dec. 2025 (lei26.1 Mil) and increased from Dec. 2025 (lei26.1 Mil) to Mar. 2026 (lei26.4 Mil).

Farmaceutica Remedia's annual retained earnings increased from Dec. 2023 (lei21.5 Mil) to Dec. 2024 (lei22.9 Mil) and increased from Dec. 2024 (lei22.9 Mil) to Dec. 2025 (lei26.1 Mil).


Farmaceutica Remedia  (LTS:0M8I) Retained Earnings Explanation

Historically profitable companies sometimes have negative retained earnings. This is because they have cumulatively paid out more to shareholders than they reported in profits.

For example, in 2011, Microsoft had negative retained earnings. This does not mean the company lost more money than it made over the years. It just means it paid out more money than it earned.

If a company has negative retained earnings, investors should check the 10-year financial results. They should not assume that negative retained earnings prove a company has generally lost money in the past.

Of course, many companies with negative retained earnings have indeed lost money in the past.

Retained Earnings: Warren Buffett's Secret.

One of the most important indicators of durable competitive advantage. Net earnings can be paid out as dividends, used to buy back shares or retained for growth.

If the company loses more than it has accumulated, retained earnings is negative.

If a company isn't adding to its retained earnings, it isn't growing its net worth.

Rate of growth of retained earnings is good indicator whether it's benefiting from a competitive advantage.

Microsoft is negative because it chose to buyback stock and pay dividends.

The more earnings retained, the faster it grows and increases growth rate for future earnings.


Farmaceutica Remedia Retained Earnings Historical Data

* Premium members only.

The historical data trend for Farmaceutica Remedia's Retained Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Farmaceutica Remedia Retained Earnings Chart

Farmaceutica Remedia Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Retained Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 13.66 17.98 21.54 22.90 26.14

Farmaceutica Remedia Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Retained Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 20.88 23.25 26.14 26.39
LTS:0M8I
59GF Score
Farmaceutica Remedia SA LTS:0M8I
Retained Earnings is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Farmaceutica Remedia Retained Earnings Calculation

Retained Earnings is the accumulated portion of net income that is not distributed to shareholders. Because the net income was not distributed to shareholders, shareholders' equity is increased by the same amount.

Of course, if a company loses, it is called retained losses, or accumulated losses.

Frequently Asked Questions Learn more about Retained Earnings →
What does a Retained Earnings of lei26.4 Mil mean?
Farmaceutica Remedia (LTS:0M8I) has a Retained Earnings of lei26.4 Mil as of Mar. 2026. Retained earnings is the amount of net income not issued to shareholders. View historical data on Farmaceutica Remedia and its competitors.
Is Farmaceutica Remedia's Retained Earnings too high?
Farmaceutica Remedia's current Retained Earnings is lei26.4 Mil. Overall, Farmaceutica Remedia has a GF Score™ of 59/100, reflecting its overall financial health beyond just this single metric.
How does Farmaceutica Remedia's Retained Earnings compare to MCK and COR?
Farmaceutica Remedia's Retained Earnings of lei26.4 Mil can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Retained Earnings for a Medical Distribution company?
A good Retained Earnings depends on the Medical Distribution industry context. However, Retained Earnings should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Retained Earnings mean?
A high Retained Earnings can signal that a stock is expensive relative to its fundamentals. Retained earnings is the amount of net income not issued to shareholders. View historical data on Farmaceutica Remedia and its competitors. Farmaceutica Remedia's current Retained Earnings is lei26.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Farmaceutica Remedia stock overvalued right now?
Farmaceutica Remedia (LTS:0M8I) has a current Retained Earnings of lei26.4 Mil. The stock's GF Value™ is lei0.23, compared to a current price of lei0.25 — trading 8.7% above its estimated fair value. The current Retained Earnings is lei26.4 Mil. Farmaceutica Remedia's overall GF Score™ is 59/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Retained Earnings calculated?
Retained Earnings is calculated from a company's financial statements. For Farmaceutica Remedia (LTS:0M8I), the current Retained Earnings is lei26.4 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Farmaceutica Remedia (LTS:0M8I) Overvalued in 2026?

Based on GuruFocus' analysis, Farmaceutica Remedia stock appears to be overvalued. The current stock price of lei0.25 is trading 8.7% above its estimated GF Value™ of lei0.23.

Key valuation signals for LTS:0M8I:

  • Retained Earnings: lei26.4 Mil
  • GF Value™: lei0.23 vs. price of lei0.25 (8.7% above fair value)
  • GF Score™: 59/100 with 8 warning signs

No single metric tells the full story. See the LTS:0M8I stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Farmaceutica Remedia Business Description

Other Exchanges RMAH:Romania
Address No. 2 Nicolae Balcescu Boulevard, Hunedoara County, Deva, ROU, 330040
Farmaceutica Remedia SA is engaged in drug sales activities, marketing, and health products. It provides marketing and promotion services for medicines. The company offers services offered, including logistics services, medical marketing, and promotion, and pharmaceutical registrations, but also professionalism and performance differentiate the company from other competitors and position it as a partner for launching, promoting, and distributing pharmaceutical products in Romania and other countries in Eastern Europe.
59GF Score

Get the complete analysis for LTS:0M8I

Retained Earnings is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

lei0.25
Price
lei0.23
GF Value